Toth Financial Advisory Corp Biomarin Pharmaceutical Inc Transaction History
Toth Financial Advisory Corp
- $795 Million
- Q1 2025
A detailed history of Toth Financial Advisory Corp transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Toth Financial Advisory Corp holds 6,105 shares of BMRN stock, worth $383,027. This represents 0.05% of its overall portfolio holdings.
Number of Shares
6,105
Previous 205
2878.05%
Holding current value
$383,027
Previous $13,000
3215.38%
% of portfolio
0.05%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding BMRN
# of Institutions
633Shares Held
184MCall Options Held
2MPut Options Held
1.67M-
Black Rock Inc. New York, NY22.7MShares$1.43 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.4MShares$1.22 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA18.2MShares$1.14 Billion0.94% of portfolio
-
Dodge & Cox San Francisco, CA14.7MShares$925 Million0.61% of portfolio
-
Capital Research Global Investors Los Angeles, CA13MShares$815 Million0.18% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $11.7B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...